{
  "report_rows": [
    {
      "kpi": "Q2 2026 diluted EPS",
      "prediction": "BEAT",
      "answer": "pred ~$7.55 vs. cons $7.23",
      "confidence": "MEDIUM"
    },
    {
      "kpi": "Q2 2026 revenue",
      "prediction": "BEAT",
      "answer": "pred ~$4.84B vs. cons $4.71B",
      "confidence": "MEDIUM"
    },
    {
      "kpi": "Q2 2026 remaining performance obligations",
      "prediction": "BEAT",
      "answer": "pred ~$16.10B vs. cons $15.90B",
      "confidence": "LOW"
    }
  ],
  "guide_rows": [
    {
      "kpi": "FY2026 revenue guidance midpoint",
      "prediction": "BETTER",
      "answer": "guide ~$19.15B vs. cons $19.00B (FY2026)",
      "confidence": "MEDIUM"
    },
    {
      "kpi": "FY2026 diluted EPS guidance midpoint",
      "prediction": "BETTER",
      "answer": "guide ~$29.90 vs. cons $29.37 (FY2026)",
      "confidence": "MEDIUM"
    }
  ],
  "day1_residual_pct": 6.0,
  "day1_confidence": "MEDIUM",
  "day5_residual_pct": 8.5,
  "day5_path": "FOLLOW-THROUGH",
  "day5_rationale": "A broad beat, near-record RPOs and higher FY2026 guidance should lift FY2026/FY2027 estimates; the sharp pre-report selloff creates room for continued recovery rather than a rapid fade.",
  "day5_confidence": "MEDIUM"
}